US FTC looks to withdraw insulin case against OptumRx to finalize deal
MLex Summary: The US Federal Trade Commission and OptumRx asked an administrative judge to withdraw the agency’s case against it over insulin prices so that they may finalize a settlement. They...To view the full article, register now.
Already a subscriber? Click here to view full article